Login / Signup

Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates.

Marco Antônio De BastianiFábio Klamt
Published in: Cancer medicine (2019)
Using an integrated transcriptomics approach, we identified master regulator candidates involved with the development and prognostic of lung adenocarcinoma, as well as potential drugs for repurposing.
Keyphrases
  • single cell
  • transcription factor
  • drug induced
  • human health
  • emergency department
  • adverse drug
  • risk assessment
  • climate change